TrialThe Journal of infectious diseases2022

Immunogenicity of a Third Scheduled Dose of Rotarix in Australian Indigenous Infants: A Phase IV, Double-blind, Randomized, Placebo-Controlled Clinical Trial.

Bianca F Middleton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.